SAVE-ONCO Trial of Thromboprophylactic Treatment with Semuloparin for Venous Thromboembolism


SAVE-ONCO Trial of Thromboprophylactic Treatment with Semuloparin for Venous Thromboembolism
Slides from a presentation at ASH 2011 and transcribed comments from a recent interview with Kenneth A Bauer, MD (1/26/12)

Agnelli G et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 2012;366(7):601-9. Abstract

George DJ et al. Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: Benefit-risk assessment by VTE risk in SAVE-ONCO. Proc ASH 2011;Abstract 206.

Dr Bauer is Professor of Medicine at Harvard Medical School, Chief of the Hematology Section of the VA Boston Healthcare System and Director of Thrombosis Clinical Research at Beth Israel Deaconess Medical Center in Boston, Massachusetts.